A
Abeona Therapeutics Inc. (ABEO)
NCM – Real Time Price. Currency in USD
5.68
-0.18 (-3.07%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
5.68
-0.18 (-3.07%)
At close: May 12, 2026, 4:00 PM EDT
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
| Name | Position |
|---|---|
| Dr. Brendan M. O'Malley J.D., Ph.D. | Chief Legal Officer |
| Dr. Madhav Vasanthavada M.B.A., Ph.D. | Chief Commercial Officer |
| Dr. Vishwas Seshadri M.B.A., Ph.D. | President, CEO & Director |
| Mr. Brian Kevany Ph.D. | Chief Technical & Scientific Officer |
| Mr. Carl Denny | Senior Vice President of Regulatory Affairs |
| Mr. Gregory Gin | Vice President of Investor Relations & Corporate Communications |
| Mr. Jon Voss | VP & Head of Quality |
| Mr. Joseph Walter Vazzano CPA | Chief Financial Officer |
| Ms. Gianine Esposito | Senior VP & Chief People Officer |
| Ms. Megan Callan | Vice President & Head of Quality |
| Date | Type | Document |
|---|---|---|
| 2026-05-04 | DEFA14A | formdefa14a.htm |
| 2026-04-27 | DEF 14A | formdef14a.htm |
| 2026-04-17 | PRE 14A | formpre14a.htm |
| 2026-04-07 | 8-K | form8-k.htm |
| 2026-03-20 | 8-K | form8-k.htm |
| 2026-03-17 | 8-K | form8-k.htm |
| 2026-03-17 | 10-K | form10-k.htm |
| 2026-03-09 | 8-K | form8-k.htm |
| 2025-11-12 | 8-K | form8-k.htm |
| 2025-11-12 | 10-Q | form10-q.htm |